Tag: Biotechnology
Gene Therapy Meeting: Addressing the Elephant in the Room
New Orleans was abuzz last year as hundreds of people gathered to listen to Peter Marks, the head of biologics at the Food and Drug Administration, speak at the American Society of Gene and...
Vinay Prasad News Impact on Biotech Stock Prices
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.Good morning, folks! Biotech had a bit of a rough day yesterday...
RFK Jr.’s Stem Cell Deregulation Roundtable: Red Flags Raised
Renowned cell biology and human anatomy professor at UC Davis School of Medicine, Paul Knoepfler, introduces a new column, Lab Dish, focusing on regenerative medicine. The recent roundtable on regenerative medicine hosted by Health...
First In Vivo Beta-Thalassemia Trial by Chinese Biotech: What to Expect
First In Vivo Beta-Thalassemia Trial by Chinese Biotech: A Groundbreaking Leap in Genetic MedicineIn a groundbreaking move that could revolutionize genetic medicine, Chinese biotech company YolTech Therapeutics has announced the initiation of the first...
Biogen CEO Plans to Acquire Biotechs: Expect Deals Ahead
Biogen CEO Eyes Biotech Acquisitions: Anticipate Major Deals in 2025SAN FRANCISCO — Chris Viehbacher, the CEO of Biogen, revealed his company's ambitious plans to acquire more biotechs in 2025. In an exclusive interview before...
Calico’s Anti-Aging Drug Fails: Key Data Revealed
Calico's Anti-Aging Drug Fails: Key Data RevealedIn a groundbreaking development that has sent shockwaves through the scientific community, Calico's highly anticipated anti-aging drug has failed. After years of speculation, anticipation, and billions of dollars...
Pfizer CEO’s Vision for Leading Cancer and Obesity Treatments
Albert Bourla, the CEO of Pfizer, is looking to shift the focus of the company from its successful COVID-19 vaccine and antiviral Paxlovid to new investments in drugs for cancer and obesity. While Pfizer's...
23andMe Board Rejects Anne Wojcicki’s Offer to Take Company Private
Anne Wojcicki, the co-founder and CEO of 23andMe, made an offer to take the company private, but the board of directors rejected her proposal. The board stated that the offer did not provide a...
BREAKING NEWS
Reforming FDA Advisory Committee Policy for Conflict of Interest-Free Decisions
Peter J. Pitts, a distinguished figure in the realm of healthcare regulation, recently shared his insights on the critical issue of FDA Advisory Committee...
